The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia Virus, Murine

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia Virus, Murine


High impact information on Leukemia Virus, Murine

  • The pol (for polymerase) gene of the murine leukemia viruses (MuLVs) is expressed in the form of a large Gag-Pol precursor protein by the suppression of translational termination, or enhanced readthrough, of a UAG stop codon at the end of gag [6].
  • Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells [7].
  • This protein was not precipitated by antisera specific for detergent-disrupted C3H-strain MMTV (C3H-MMTV); C3H-MMTV glycoproteins; C3H-MMTV nonglycosylated proteins; GR-MMTV p25 or p12; RIII strain (milk) MMTV proteins; or Rauscher murine leukemia virus (R-MuLV) proteins; nor was it precipitated by normal rabbit serum [8].
  • Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA [9].
  • Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction [10].

Chemical compound and disease context of Leukemia Virus, Murine


Biological context of Leukemia Virus, Murine


Anatomical context of Leukemia Virus, Murine


Gene context of Leukemia Virus, Murine


Analytical, diagnostic and therapeutic context of Leukemia Virus, Murine


  1. Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro. Hankins, W.D., Troxler, D. Cell (1980) [Pubmed]
  2. Mechanism of RNA polymerase II--specific initiation of transcription in vitro: ATP requirement and uncapped runoff transcripts. Bunick, D., Zandomeni, R., Ackerman, S., Weinmann, R. Cell (1982) [Pubmed]
  3. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. Simon, J.H., Miller, D.L., Fouchier, R.A., Soares, M.A., Peden, K.W., Malim, M.H. EMBO J. (1998) [Pubmed]
  4. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Levin, J.G., Rosenak, M.J. Proc. Natl. Acad. Sci. U.S.A. (1976) [Pubmed]
  5. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. DeLeo, A.B., Jay, G., Appella, E., Dubois, G.C., Law, L.W., Old, L.J. Proc. Natl. Acad. Sci. U.S.A. (1979) [Pubmed]
  6. Reverse transcriptase of Moloney murine leukemia virus binds to eukaryotic release factor 1 to modulate suppression of translational termination. Orlova, M., Yueh, A., Leung, J., Goff, S.P. Cell (2003) [Pubmed]
  7. Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells. Stephens, E.B., Compans, R.W. Cell (1986) [Pubmed]
  8. A unique glycoprotein containing GR-mouse mammary tumor virus peptides and additional peptides unrelated to viral structural proteins. Anderson, S.J., Naso, R.B. Cell (1980) [Pubmed]
  9. Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA. Murphy, E.C., Kopchick, J.J., Watson, K.F., Arlinghaus, R.B. Cell (1978) [Pubmed]
  10. Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Rein, A., Kashmiri, S.V., Bassin, R.H., Gerwin, B.L., Duran-Troise, G. Cell (1976) [Pubmed]
  11. A murine leukemia virus mutant with a temperature-sensitive defect in membrane glycoprotein synthesis. Ruta, M., Murray, M.J., Webb, M.C., Kabat, D. Cell (1979) [Pubmed]
  12. Antibodies in human sera to oncorna virus-like proteins from normal or leukemia marrow cell cultures. Louie, S., Curtis, J.E., Till, J.E., McCulloch, E.A. J. Exp. Med. (1976) [Pubmed]
  13. Antiviral effects of amino acid derivatives with the fluorene substituent on murine leukemia viruses. Fujita, H., Toyoshima, S. J. Natl. Cancer Inst. (1983) [Pubmed]
  14. Vaccination with a live retrovirus: the nature of the protective immune response. Ruprecht, R.M., Mullaney, S., Bernard, L.D., Gama Sosa, M.A., Hom, R.C., Finberg, R.W. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  15. Disassembly of viral membranes by complement independent of channel formation. Esser, A.F., Bartholomew, R.M., Jensen, F.C., Müller-Eberhard, H.J. Proc. Natl. Acad. Sci. U.S.A. (1979) [Pubmed]
  16. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Chatis, P.A., Holland, C.A., Hartley, J.W., Rowe, W.P., Hopkins, N. Proc. Natl. Acad. Sci. U.S.A. (1983) [Pubmed]
  17. Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Elder, J.H., Gautsch, J.W., Jensen, F.C., Lerner, R.A., Hartley, J.W., Rowe, W.P. Proc. Natl. Acad. Sci. U.S.A. (1977) [Pubmed]
  18. Evidence that a downstream pseudoknot is required for translational read-through of the Moloney murine leukemia virus gag stop codon. Wills, N.M., Gesteland, R.F., Atkins, J.F. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  19. Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells. Wilcox, D.A., Olsen, J.C., Ishizawa, L., Griffith, M., White, G.C. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  20. Nucleotide sequences associated with differences in electrophoretic mobility of envelope glycoprotein gp70 and with GIX antigen phenotype of certain murine leukemia viruses. Donis-Keller, H., Rommelaere, J., Ellis, R.W., Hopkins, N. Proc. Natl. Acad. Sci. U.S.A. (1980) [Pubmed]
  21. Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. Morse, H.C., Roths, J.B., Davidson, W.F., Langdon, W.Y., Fredrickson, T.N., Hartley, J.W. J. Exp. Med. (1985) [Pubmed]
  22. Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen: mapping of the locus involved to the I region of the H-2 complex. Meruelo, D., Deak, B., McDevitt, H.O. J. Exp. Med. (1977) [Pubmed]
  23. Murine leukemia viruses: induction of macrophage production of granulocyte-macrophage colony-stimulating factor in vitro. Greenberger, J.S., Wroble, L.M., Sakakeeny, M.A. J. Natl. Cancer Inst. (1980) [Pubmed]
  24. Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progression. Berlingieri, M.T., Portella, G., Grieco, M., Santoro, M., Fusco, A. Mol. Cell. Biol. (1988) [Pubmed]
  25. Purification of a glycoprotein from mouse ascites fluid by immunoaffinity chromatography which is related to the major glycoprotein of murine leukemia viruses. Immunologic and structural comparison with purified viral glycoproteins. Kennel, S.J. J. Biol. Chem. (1976) [Pubmed]
  26. Transfection of Fv-1 permissive and restrictive mouse cells with integrated DNA of murine leukemia viruses. Hsu, I.C., Yang, W.K., Tennant, R.W., Brown, A. Proc. Natl. Acad. Sci. U.S.A. (1978) [Pubmed]
  27. Identification of human VPS37C, a component of endosomal sorting complex required for transport-I important for viral budding. Eastman, S.W., Martin-Serrano, J., Chung, W., Zang, T., Bieniasz, P.D. J. Biol. Chem. (2005) [Pubmed]
  28. Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: control by a single dominant locus on chromosome 1. Kozak, C.A. J. Virol. (1985) [Pubmed]
  29. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. Chazal, N., Singer, G., Aiken, C., Hammarskjöld, M.L., Rekosh, D. J. Virol. (2001) [Pubmed]
  30. A gene delivery system activatable by disease-associated matrix metalloproteinases. Peng, K.W., Morling, F.J., Cosset, F.L., Murphy, G., Russell, S.J. Hum. Gene Ther. (1997) [Pubmed]
  31. Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. DeLarco, J., Todaro, G.J. Cell (1976) [Pubmed]
  32. The morphology of murine oncornaviruses following different methods of preparation for electron microscopy. Sarkar, N.H., Manthey, W.J., Sheffield, J.B. Cancer Res. (1975) [Pubmed]
  33. Fv-1 determinants in xenotropic murine leukemia viruses studied with biological assay systems: Isolation of xenotropic virus with N-tropic Fv-1 activity in the cryptic form. Sakai, K., Narita, H., Adachi, A., Tsuruta, S., Yorifuji, T., Ishimoto, A. J. Virol. (1982) [Pubmed]
  34. Effect of the Fv-1 locus on the titration of murine leukemia viruses. Jolicoeur, P., Baltimore, D. J. Virol. (1975) [Pubmed]
  35. Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus. Jolicoeur, P., Nicolaiew, N., DesGroseillers, L., Rassart, E. J. Virol. (1983) [Pubmed]
WikiGenes - Universities